Rare diseases are rapidly becoming a high priority therapeutic area for our industry. This is needed, especially when fewer than 5% of approx 7,000 rare diseases have drug therapies available, and many of these provide limited benefit. There is also a business case to this, due to a supportive reimbursement environment, particularly in the US. […]
Read More →Rare disease drug development is a rapidly expanding field with growing pressure for getting a more orphan drugs approved to treat rare diseases. There is a vast consensus among patients, health care bodies, governments, etc. to expedite drug development in this field. Some wonderful numbers that attest to growing interest in rare diseases and orphan […]
Read More →The United States is the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies requires considering many factors and areas. In the first part of this series of articles for clinical trials in the United States, we have seen the regulatory situation, clinical sites, and […]
Read More →Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum. Globally, colorectal cancer is the third most common type of cancer in both men and women making up about 10% of all cases. Currently, there is a significant focus on the development of drugs […]
Read More →The Gastrointestinal (GI) drugs market is a potentially huge market with many different indications, drug types, and treatment regimens. Transparency Market Research and PRNewswire reports predict the global GI drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. While it was worth USD 46.5 Billion in 2016, […]
Read More →Alopecia is a condition in which hairs are lost from some or all areas of the body. In fact, alopecia areata is also known as spot baldness for this reason. Most commonly, patients have bald spots on their scalps about the size of a coin. There are three (3) well-known types of Alopecia Alopecia areata […]
Read More →Acute vestibulopathy is characterized by an acute or subacute onset of vertigo, dizziness, or imbalance with or without ocular motor, sensory, postural or autonomic symptoms, and signs, and can last for seconds to up to several days. What is Acute Unilateral Vestibulopathy? Normal vestibular end organs generate an equal resting-firing frequency of the axons, which […]
Read More →The best reasons to conduct clinical trials in any country include the availability of patients, clarity of regulatory processes, willing and qualified investigators, and sound infrastructure with a reasonable cost. This is what you get if you conduct clinical trials in Romania. Let’s see this in greater detail. Brief demography Romania is a sovereign state located in Southeastern […]
Read More →Poland is regarded as one of the largest clinical trials markets in CEE/CIS. In a report in 2010, PriceWaterhouseCoopers (PwC) pointed out that with 469 new clinical trial registrations in 2009, Poland accounted for c. 2.5%-3.0% of the world market by registration volumes. Current status of clinical research in Poland The status of clinical research has […]
Read More →Identification and selection of clinical trial sites and clinical investigators remain one of the first and most crucial decisions that clinical trial managers take. This also happens to be the one that may define the success (or, failure) of the project. We had been seeing the impact of site/investigator identification on clinical trial successes time […]
Read More →